AGN 2979: RN given refers to parent cpd; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 176887 |
CHEMBL ID | 2105157 |
SCHEMBL ID | 2111508 |
MeSH ID | M0140003 |
Synonym |
---|
agn 2979 |
metamfazone |
4-amino-6-methyl-2-phenylpyridazin-3-one |
6q0yu79408 , |
3(2h)-pyridazinon, 4-amino-6-methyl-2-phenyl- |
metamfazonum |
agn 20 |
unii-6q0yu79408 |
4-amino-6-methyl-2-phenyl-3(2h)-pyridazinon |
54063-49-9 |
4-amino-6-methyl-2-phenyl-3(2h)-pyridazinone |
metamfazone [inn:ban:dcf] |
methamphazone |
agn-20 |
CHEMBL2105157 |
metamfazone [inn] |
SCHEMBL2111508 |
DTXSID30202393 |
4-amino-6-methyl-2-phenylpyridazin-3(2h)-one |
aceticacid4-methoxy-pyridin-2-ylmethylester |
Q27265304 |
AKOS040753009 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (11.11%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models. Japanese journal of pharmacology, Volume: 61, Issue: 2 | 1993 |
An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD) Progress in neuro-psychopharmacology & biological psychiatry, Volume: 18, Issue: 4 | 1994 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |